[HTML][HTML] Exploring the role of immune system and inflammatory cytokines in SARS-CoV-2 induced lung disease: a narrative review
C Tirelli, M De Amici, C Albrici, S Mira, G Nalesso, B Re…�- Biology, 2023 - mdpi.com
Simple Summary Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
responsible for the pandemic coronavirus disease-2019 (COVID-19), which can lead to�…
responsible for the pandemic coronavirus disease-2019 (COVID-19), which can lead to�…
[HTML][HTML] Characterization of SARS-CoV-2-specific humoral immunity and its potential applications and therapeutic prospects
J Zheng, Y Deng, Z Zhao, B Mao, M Lu, Y Lin…�- Cellular & molecular�…, 2022 - nature.com
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is an ongoing pandemic that poses a great threat to�…
syndrome coronavirus 2 (SARS-CoV-2), is an ongoing pandemic that poses a great threat to�…
[HTML][HTML] SARS-CoV-2-specific T cells in infection and vaccination
During viral infections, antibodies and T cells act together to prevent pathogen spread and
remove virus-infected cells. Virus-specific adaptive immunity can, however, also trigger�…
remove virus-infected cells. Virus-specific adaptive immunity can, however, also trigger�…
[HTML][HTML] T cell immunity to SARS-CoV-2
Exceptional efforts have been undertaken to shed light into the biology of adaptive immune
responses to SARS-CoV-2. T cells occupy a central role in adaptive immunity to mediate�…
responses to SARS-CoV-2. T cells occupy a central role in adaptive immunity to mediate�…
Divergent SARS‐CoV‐2‐specific T‐and B‐cell responses in severe but not mild COVID‐19 patients
AE Oja, A Saris, CA Ghandour…�- European journal of�…, 2020 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is the causative agent of
the current coronavirus disease 2019 (COVID‐19) pandemic. Understanding the immune�…
the current coronavirus disease 2019 (COVID‐19) pandemic. Understanding the immune�…
Papel del sistema inmune en la infecci�n por el SARS-CoV-2: inmunopatolog�a de la COVID-19
JM Sanz, AMG Lahoz, RO Mart�n�- Medicine-Programa de Formaci�n�…, 2021 - Elsevier
El sistema inmune es capaz de controlar adecuadamente la infecci�n por el SARS-CoV-2
en un 81% de los pacientes, cursando de una forma asintom�tica o con sintomatolog�a�…
en un 81% de los pacientes, cursando de una forma asintom�tica o con sintomatolog�a�…